UNSPSC 51281820: Esorubicin hydrochloride

This classification denotes an anthracycline antibiotic C27H29NO10.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2UB1JJT82D, chemically known as (8s,10s)-10-(((2s,4r,6s)-4-aminotetrahydro-6-methyl-2h-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride, but more generally known as esorubicin hydrochloride, which bears US NIH Compound Identifier 152035. Most nations, for tariff and trade purposes, schedule esorubicin hydrochloride under HS 29419000 and SITC 54139.

As of Q4 2014, ESORUBICIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Esorubicin hydrochloride bears US NLM identifiers UMLS ID C2700018 and NCI Concept Code C74943. SMILES: C[C@H]1C[C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3C2C(C4C(C3O)C(=O)C5CCCC(C5C4=O)OC)O)(C(=O)CO)O)N.CL.

UNSPSC 51281820 Esorubicin hydrochloride is a Commodity code that nominally covers a single chemotherapy drug product, but recent state and local solicitations tagged under this code show little alignment with the code's stated scope. The recent opportunities in the block reflect procurement of naloxone and drug deactivation systems, direct-to-manufacturer pharmacy programs, general medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and OTC products — none of which are esorubicin hydrochloride or closely related oncology therapeutics. The mismatch suggests that state and local procurement systems are applying this code inconsistently or that the opportunities have been mislabeled in the source data. This code shows no meaningful recent activity in its actual commodity scope.

Geographic activity appears scattered across Florida (Seminole County), Texas (state HHS commission), and multi-state cooperative purchasing (Minnesota MMCAP with Oregon participation), though the connection between these opportunities and esorubicin hydrochloride procurement is unclear. The issuing bodies include a county health department, a state health and human services agency, a city fire department, and a multi-state cooperative purchasing organization. Representative recent solicitations include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's IFB for medical and first aid supplies for fire rescue (due March 13, 2026, with an estimated contract value of $700,000), and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026). Without solicitations specifically targeting esorubicin hydrochloride or related oncology therapeutics, this code presents limited pursuit opportunity under its stated commodity definition.